Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 39.59% vs 16.65% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 76.42% vs 12.73% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "431.20",
          "val2": "308.90",
          "chgp": "39.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "176.90",
          "val2": "122.10",
          "chgp": "44.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.30",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "23.70",
          "val2": "9.20",
          "chgp": "157.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "176.60",
          "val2": "100.10",
          "chgp": "76.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "410.30%",
          "val2": "294.70%",
          "chgp": "11.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 252.54% vs 17.75% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 318.27% vs 143.97% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,195.90",
          "val2": "1,190.20",
          "chgp": "252.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,244.40",
          "val2": "334.50",
          "chgp": "869.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "1.40",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "50.50",
          "val2": "28.90",
          "chgp": "74.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,891.90",
          "val2": "691.40",
          "chgp": "318.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "743.70%",
          "val2": "173.60%",
          "chgp": "57.01%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

431.20

308.90

39.59%

Operating Profit (PBDIT) excl Other Income

176.90

122.10

44.88%

Interest

0.00

0.30

-100.00%

Exceptional Items

23.70

9.20

157.61%

Consolidate Net Profit

176.60

100.10

76.42%

Operating Profit Margin (Excl OI)

410.30%

294.70%

11.56%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 39.59% vs 16.65% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 76.42% vs 12.73% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

4,195.90

1,190.20

252.54%

Operating Profit (PBDIT) excl Other Income

3,244.40

334.50

869.93%

Interest

0.70

1.40

-50.00%

Exceptional Items

50.50

28.90

74.74%

Consolidate Net Profit

2,891.90

691.40

318.27%

Operating Profit Margin (Excl OI)

743.70%

173.60%

57.01%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 252.54% vs 17.75% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 318.27% vs 143.97% in Dec 2024

All Annual Results